In a significant move to combat the devastating synthetic opioid crisis, particularly the role played by China, President Donald J. Trump has signed an Executive Order eliminating the duty-free de minimis exemption for low-value imports from the People's Republic of China (PRC) and Hong Kong. This episode breaks down the details of this new policy, its intended impact, and the broader context of the fight against fentanyl and other illicit drugs entering the United States.